Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
Recent breakthroughs in senolytic and senomorphic therapies, including polyunsaturated lipids inducing ferroptosis, are advancing clinical trials for age-related diseases, with a focus on safety and b...
Recent breakthroughs in epigenetic clocks, particularly DunedinPACE, enhance mortality prediction accuracy by up to 20%, validated by studies like BASE-II, and drive innovations in personalized medici...
Recent studies reveal complement system biomarkers, such as C3 and C4, change with age and correlate with dementia, offering potential for early Alzheimer’s detection and insights into immune sy...
Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
A 2023 meta-analysis confirms GrimAge epigenetic age acceleration consistently predicts frailty, enabling early risk assessment and personalized interventions for elderly health. Recent studies show e...
New research shows simple balance assessments can predict cellular aging and mortality risk with surprising accuracy, revolutionizing preventive health approaches for older adults. Three simple balanc...
Recent human trials reveal BPC-157’s potential for tendon and joint recovery, with promising angiogenic effects and favorable safety profiles, though long-term risks remain uncertain. Emerging h...
Recent studies highlight the role of omega-3 fatty acids, vitamin D, and Mediterranean diets in reducing arthralgia for breast cancer patients on endocrine therapy. Emerging research suggests that per...
A 12-week clinical trial evaluates the safety and feasibility of time-restricted eating in early-stage Huntington’s disease, focusing on metabolic outcomes and disease biomarkers. A new clinical...
